Photodynamic therapy repairs medication-related osteonecrosis of the jaw by reducing NF-kB protein in rats

J Appl Oral Sci. 2024 Apr 29:32:e20230447. doi: 10.1590/1678-7757-2023-0447. eCollection 2024.

Abstract

Objective: To evaluate whether antimicrobial photodynamic therapy (aPDT) repairs bisphosphonate-related osteonecrosis of the jaw (BRONJ) modulated by the reduction of NF-kB protein in a murine model.

Methodology: Male Wistar rats (N=30) were divided into the following groups (n=6/group): negative control (NC); experimental osteonecrosis (ONE); ONE + photosensitizer (PS); ONE + photobiomodulation (PBM); and ONE + aPDT. Over 8 weeks, ONE was induced by zoledronic acid 250 µg/kg injections, except in the NC group, which received sterile 0.9% saline, followed by extraction of the lower left first molar. Red light laser irradiation (wavelength ~660 nm, power 50 mW, energy of 2 J, energy dose of 66.67 J/cm2 for 40 s) was performed once a week for 4 weeks. Methylene blue 0.3% was used as PS. The animals were euthanized and examined macroscopically for the presence of exposed bone and epithelial repair and microscopically by histochemical (hematoxylin-eosin and Masson's trichrome staining) and immunohistochemical (anti-NF-kB) methods. Macroscopic and histomorphometric data were analyzed by one-way ANOVA and Tukey's post-test (p<0.05).

Results: Mucosal repair, viable osteocytes, and NF-kB immunostaining were observed in the NC, ONE+PS, ONE+PBM, and ONE+aPDT groups. The ONE group showed no mucosal repair, showing empty lacunae and multifocal immunostaining for NF-kB. The ONE+PBM and ONE+aPDT groups had greater deposition of extracellular matrix and less necrotic bone tissue (p<0.05).

Conclusion: PBM and aPDT treatments for BRONJ were effective for bone and epithelial repair, in addition to reducing inflammation mediated by the decrease of NF-kB protein in the irradiated regions.

Publication types

  • Evaluation Study

MeSH terms

  • Analysis of Variance
  • Animals
  • Bisphosphonate-Associated Osteonecrosis of the Jaw* / pathology
  • Bone Density Conservation Agents / pharmacology
  • Diphosphonates / pharmacology
  • Disease Models, Animal*
  • Imidazoles / pharmacology
  • Immunohistochemistry*
  • Low-Level Light Therapy / methods
  • Male
  • Methylene Blue / pharmacology
  • Methylene Blue / therapeutic use
  • NF-kappa B* / analysis
  • Photochemotherapy* / methods
  • Photosensitizing Agents* / pharmacology
  • Random Allocation
  • Rats, Wistar*
  • Reproducibility of Results
  • Time Factors
  • Treatment Outcome
  • Zoledronic Acid / pharmacology

Substances

  • NF-kappa B
  • Photosensitizing Agents
  • Zoledronic Acid
  • Imidazoles
  • Diphosphonates
  • Methylene Blue
  • Bone Density Conservation Agents